|
⚲
|
| Keyboard |
| Altrartis Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002157050 |
| Sale | 2026-08-12 (11.0 M Offered, 11.0 M Sold) |
| Fund | |
| Phone | 4921187973990185 |
| Address | 228 Park Ave S 505778 New York, NY 10003-1502 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-10-22 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Lars Christian Wilde | Director | |
| Florian Brand | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Sestante Capital LLC
✚
|
NY | |
|
BlueCrest Capital Management New York LP
✚
|
NY | |
|
The Mannsion Group LLC
✚
|
NY | |
|
Wolfe Research Advisors LLC
✚
|
NY | |
|
Millville Opportunities Management LLC
✚
|
NY | |
|
Vorynto Exchange Ltd
✚
|
NY | |
|
Altalis Capital Management LLC
✚
|
NY | |
|
Duane Park Capital Management LP
✚
|
NY | |
|
Calvion Capital Management LP
✚
|
NY | |
|
Harbor Spring Capital LLC
✚
|
NY |